Concise Analysis on the International Coagulation Self-Testing Devices, Markets, Players and Prospects - WTRF 7 News Sports Weather - Wheeling Steubenville

Concise Analysis on the International Coagulation Self-Testing Devices, Markets, Players and Prospects

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact

SOURCE Research and Markets

DUBLIN, Feb. 11, 2014 /PRNewswire/ --

Research and Markets


) has announced the addition of the

"Concise Analysis on the International Coagulation Self-Testing Devices, Markets, Players and Prospects"

report to their offering.


The ability of patients to self-monitor is deemed to be a critical tool in reducing the pathological effects of difficult-to-control disease factors. For the millions of patients in the US and worldwide prescribed warfarin for oral anticoagulation therapy (OAT), the ability to monitor coagulation rates and adjust drug dosage to optimize therapeutic outcomes is a critical element of patient care. The availability of self-testing monitors provides patients with an opportunity to self-test and avoid frequent caregiver visits. Compared to blood glucose monitoring, OAT self-testing presents a higher level of complexity and risk, placing a premium on patient education.

A number of companies are now providing services to patients wishing to self-test, acting as a first-line patient resource and assisting with device selection and patient training. Wirelessly-enabled devices that allow patients to share readings with physicians electronically provide an additional safety and compliance benefit. While still a small percentage of all patients, as demographics and awareness drive increases in the diagnosed incidence of underlying conditions, patient self-testing for OAT will increasingly migrate from caregiver facilities and into homes.


  • Analyzes marketed patient self-testing devices for measuring and monitoring anticoagulation drug therapy
  • Evaluates the status and prospects of coagulation self-test devices currently in development
  • Assesses the market potential and commercialization risks and opportunities for coagulation self-test devices
  • Examines the role and impact of third-party PT/INR self-test services on device demand and patient acceptance
  • Provides market data and forecasts to 2018
  • Profiles market participants, their technology, product development activity, and business strategies

Key Topics Covered:

Executive Summary

Anticoagulation Therapy Market Dynamics

Anticoagulation Economics
Oral Anticoagulation Therapy
Monitoring Prothrombin Time
Competing Anticoagulation Tests
Key Factors in Patient Compliance
Market Drivers
Industry Alignment and Competitive Landscape

Coagulation Self-Testing Device Design Factors

Standardization of PT/INR Testing
Accuracy and Precision
Sampling Method
Endpoint Detection
Patient/User Interface
Connectivity & Data Collection

Commercialization Factors

Managed Care and Reimbursement
Patient Training and Education
Third-Party Self-Testing Services
Market Factors
Regulations and Standards
Patient/Consumer Sentiment
Regional Demand and Demographics
Alliances and Partnerships
Proprietary Technology
Patient Self-Testing Product Assessments
Development-Stage Devices
iLine Microsystems
Universal Biosensors
Zin Technologies

Market Analysis, Data and Forecasts

Indications and Demographics
Therapeutic Market Segments
New Technology & Pipeline Prospects
Geographic Markets

Market Participant Profiles

For more information visit

Media Contact: Laura Wood , +353-1-481-1716,

©2012 PR Newswire. All Rights Reserved.